NCT07539974Not yet recruiting
Effect of Inspiratory Muscle Training on Diaphragm Function in COPD Patients
Effect of Threshold Inspiratory Muscle Training on Diaphragm Thickness and Diaphragm Excursion Value in Chronic Obstructive Pulmonary Disease Patients
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
This study investigates the effect of threshold inspiratory muscle training on diaphragm thickness and diaphragm excursion, measured using ultrasonography, in patients with stable chronic obstructive pulmonary disease (COPD).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 13 Apr 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- Universitas Padjadjaran
- Diseases
- COPD
- NCT number
- NCT07539974
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 1 Apr 2026 to the primary completion date, 1 Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing other therapies that may affect diaphragmatic muscle measurement results, such as electrical diaphragmatic stimulation
Other illness
- Patients with contraindications to Inspiratory Muscle Training or spirometry (e.g., recent thoracic or abdominal surgery, pneumothorax, or history of spontaneous pneumothorax).
Other
- Patients participating in other structured respiratory muscle training or pulmonary rehabilitation programs concurrently that could confound the results
Who the study is looking for
- Patients with a COPD GOLD stage 2
- Age 40-59 years
- Maximal Inspiratory Pressure (MIP) value of less than 70 cmH₂O or below the lower limit of normal for their age and gender
- Clinically stable for at least 4 weeks prior to the study
- Ready to participate in research and sign informed consent
Age in the registry: 40 years to 59 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.